Karo Pharma Smart choices for everyday healthcare About Products Karo Everyday Investors News & Press English Corporate Governance Karo Pharma applies the Swedish Code of Corporate Governance (“the Code”). This section of the website contains information and documents relating to corporate governance. Comments are made in the appropriate section of the annual Corporate Governance Report for any deviations that the company has decided to make from the Code. The Corporate Governance Report is reviewed annually by the company’s auditor. The highest decision-making body is the General Meeting of shareholders, where the shareholders exercise their influence in the company. Each share equates to one vote. The Annual General Meeting is held within six months of the end of the financial year. At the Annual General Meeting, the shareholders adopt resolutions regarding such matters as the election of the members of the Board of Directors and, where appropriate, the auditors, the appointment of the Nominating Committee and discharge from responsibility for the members of the Board of Directors and the CEO for the previous year. Resolutions are also adopted regarding the preparation of the financial statements, the allocation of profit, the fees for the Board of Directors and auditors and guidelines for the remuneration of the President and other senior executives. Related documents Styrelsens redovisning av utvärdering av ersättningar Corporate Governance report 2015 Corporate Governance report 2014 Corporate Governance report 2013 Corporate Governance report 2012 Corporate Governance report 2011 Corporate Governance report 2010 NOMINATING COMMITTEE AUDIT ARTICLES OF ASSOCIATION Products Financial reports Financial Press releases Contact Karo Pharma Follow us on LinkedIn Copyright© Karo Pharma AB 2021 Cookies are required for our website to function optimally and to improve the user experience. By browsing further, you accept our use of cookies.» Privacy policy Approve

Karo Pharma Smart choices for everyday healthcare About Products Karo Everyday Investors News & Press English Calendar February 18 2021, Year-end report 2020, 2pm Week 13 2021, Annual report 2020 April 21 2021, Annual General Meeting, 3pm – 5pm April 21 2021, Interim report Jan-Mar 2021 July 22 2021, Interim report Jan-Jun 2021 October 28 2021, Interim report Jan-Sep 2021 February 16 2022, Year-end report 2021 Products Financial reports Financial Press releases Contact Karo Pharma Follow us on LinkedIn Copyright© Karo Pharma AB 2021 Cookies are required for our website to function optimally and to improve the user experience. By browsing further, you accept our use of cookies.» Privacy policy Approve